Brampton, Canada

Narendrakumar B Patel

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Zealand Pharma A/s. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Narendrakumar B Patel. Retrieved from https://idiyas.com/inventor/narendrakumar-b-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Narendrakumar B Patel: Innovator in Cyclic Peptides

Introduction

Narendrakumar B Patel is a notable inventor based in Brampton, Canada. He has made significant contributions to the field of cyclic peptides, with a focus on developing multimers that target specific integrins. His innovative work has led to the filing of three patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Narendrakumar's latest patents include "Cyclic peptides multimers targeting α4β7 integrin." This patent describes multimers comprising a plurality of compounds covalently linked together, with the compounds independently being of formula (I). Another patent with a similar title further emphasizes his focus on cyclic peptides and their potential applications in therapeutic settings.

Career Highlights

Narendrakumar B Patel is currently associated with Zealand Pharma A/S, where he continues to push the boundaries of innovation in peptide research. His work is instrumental in developing new therapeutic strategies that could benefit patients with various medical conditions.

Collaborations

Some of his notable coworkers include Mohammed Monzur Morshed and Sai Kumar Chakka. Their collaborative efforts contribute to the dynamic research environment at Zealand Pharma A/S.

Conclusion

Narendrakumar B Patel's contributions to the field of cyclic peptides and his innovative patents highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in targeted therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…